Our data support the model that Plexin-B2 is usurped by GBM cells to enhance invasiveness, counter durotaxis, negotiate vascular vs. axonal substrates, and respond to different properties of the substrate they mobilize on. This evidence concerns the gene PLXNB2 and glioblastoma.